Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $31,781 | 15 | 57.1% |
| Travel and Lodging | $15,446 | 14 | 27.7% |
| Grant | $5,170 | 3 | 9.3% |
| Food and Beverage | $2,745 | 33 | 4.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $500.00 | 1 | 0.9% |
| Education | $24.93 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Covidien LP | $15,755 | 13 | $0 (2020) |
| AstraZeneca UK Limited | $13,965 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $10,460 | 14 | $0 (2024) |
| GENZYME CORPORATION | $7,759 | 8 | $0 (2017) |
| Medtronic, Inc. | $3,554 | 5 | $0 (2023) |
| Genentech USA, Inc. | $1,363 | 1 | $0 (2021) |
| Edwards Lifesciences Corporation | $1,042 | 4 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $750.00 | 1 | $0 (2019) |
| Intuitive Surgical, Inc. | $460.91 | 3 | $0 (2023) |
| NOVADAQ TECHNOLOGIES INC. | $166.44 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,291 | 4 | AstraZeneca Pharmaceuticals LP ($1,256) |
| 2023 | $4,149 | 8 | AstraZeneca Pharmaceuticals LP ($2,303) |
| 2022 | $2,019 | 5 | Medtronic, Inc. ($1,904) |
| 2021 | $10,964 | 8 | AstraZeneca UK Limited ($9,398) |
| 2020 | $4,130 | 4 | AstraZeneca UK Limited ($2,282) |
| 2019 | $11,934 | 12 | AstraZeneca Pharmaceuticals LP ($6,901) |
| 2018 | $13,051 | 13 | Covidien LP ($9,726) |
| 2017 | $8,128 | 13 | GENZYME CORPORATION ($7,759) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,074.00 | General |
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $132.22 | General |
| 09/09/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Oncology | ||||||
| 06/02/2024 | AstraZeneca UK Limited | — | Food and Beverage | In-kind items and services | $35.00 | General |
| 12/12/2023 | OrganOx Ltd | METRA (Device) | Food and Beverage | Cash or cash equivalent | $77.89 | General |
| Category: TRANSPLANT SURGERY | ||||||
| 09/23/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $117.58 | General |
| Category: SURGERY | ||||||
| 09/23/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $60.61 | General |
| 09/21/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $32.80 | General |
| 09/13/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $61.48 | General |
| 08/11/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Consulting Fee | Cash or cash equivalent | $2,148.00 | General |
| Category: Oncology | ||||||
| 07/19/2023 | Medtronic, Inc. | SIGNIA (Device) | Food and Beverage | In-kind items and services | $155.80 | General |
| Category: Surgical Stapling | ||||||
| 02/03/2023 | Medtronic, Inc. | — | Grant | Cash or cash equivalent | $1,494.51 | General |
| 10/31/2022 | Abbott Laboratories | PORTICO (Device) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Structural Heart | ||||||
| 09/27/2022 | Novocure Inc. | — | Food and Beverage | Cash or cash equivalent | $96.42 | General |
| 04/21/2022 | Medtronic, Inc. | SIGNIA (Device) | Food and Beverage | In-kind items and services | $220.95 | General |
| Category: Surgical Stapling | ||||||
| 04/21/2022 | Medtronic, Inc. | SIGNIA (Device) | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: Surgical Stapling | ||||||
| 03/10/2022 | Medtronic, Inc. | — | Grant | Cash or cash equivalent | $1,675.00 | General |
| 10/28/2021 | Genentech USA, Inc. | TECENTRIQ (Biological) | Consulting Fee | Cash or cash equivalent | $1,362.50 | General |
| Category: BioOncology | ||||||
| 08/12/2021 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $537.00 | General |
| 07/01/2021 | BIOTRONIK INC. | BioMonitor (Device), Solia, Rivacor | Education | In-kind items and services | $24.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/20/2021 | AstraZeneca UK Limited | TAGRISSO (Drug) | Consulting Fee | Cash or cash equivalent | $2,148.00 | General |
| Category: Oncology | ||||||
| 05/17/2021 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $2,685.00 | General |
| 05/13/2021 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $1,879.50 | General |
| 04/13/2021 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $2,148.00 | General |
| 03/26/2021 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $178.69 | General |
| Category: SURGERY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 411 | 508 | $755,635 | $90,350 |
| 2022 | 9 | 472 | 554 | $972,155 | $120,876 |
| 2021 | 11 | 477 | 555 | $1.4M | $153,333 |
| 2020 | 8 | 399 | 466 | $786,156 | $89,106 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 211 | 308 | $189,420 | $24,752 | 13.1% |
| 32663 | Exam of lung with removal of lung lobe using an endoscope | Facility | 2023 | 16 | 16 | $169,520 | $21,075 | 12.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 126 | 126 | $148,050 | $20,294 | 13.7% |
| 32666 | Initial removal of wedge of lung tissue using an endoscope | Facility | 2023 | 21 | 21 | $166,320 | $16,790 | 10.1% |
| 32674 | Removal of lymph nodes of chest cavity using an endoscope | Facility | 2023 | 37 | 37 | $82,325 | $7,439 | 9.0% |
| 32663 | Exam of lung with removal of lung lobe using an endoscope | Facility | 2022 | 20 | 20 | $211,120 | $27,208 | 12.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 195 | 275 | $155,670 | $24,042 | 15.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 125 | 125 | $137,500 | $21,055 | 15.3% |
| 32669 | Removal of segment of lung tissue using an endoscope | Facility | 2022 | 13 | 13 | $151,580 | $17,391 | 11.5% |
| 32666 | Initial removal of wedge of lung tissue using an endoscope | Facility | 2022 | 18 | 19 | $150,480 | $16,560 | 11.0% |
| 32674 | Removal of lymph nodes of chest cavity using an endoscope | Facility | 2022 | 47 | 47 | $104,575 | $10,116 | 9.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 14 | $10,530 | $1,897 | 18.0% |
| 31622 | Diagnostic exam of lung airway using an endoscope | Facility | 2022 | 27 | 27 | $45,225 | $1,740 | 3.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 14 | $5,475 | $867.57 | 15.8% |
| 43287 | Removal of lower esophagus and partial removal of stomach using an endoscope | Facility | 2021 | 13 | 13 | $367,250 | $46,716 | 12.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 188 | 257 | $145,205 | $22,405 | 15.4% |
| 32669 | Removal of a segment of lung tissue using an endoscope | Facility | 2021 | 12 | 19 | $228,536 | $20,779 | 9.1% |
| 32663 | Examination of lung with removal of lung lobe using an endoscope | Facility | 2021 | 14 | 14 | $151,840 | $19,657 | 12.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 112 | 112 | $123,200 | $18,504 | 15.0% |
| 32674 | Removal of lymph nodes of mid-chest cavity using an endoscope | Facility | 2021 | 46 | 47 | $104,575 | $10,165 | 9.7% |
| 44186 | Creation of small bowel opening using an endoscope for decompression or feeding | Facility | 2021 | 19 | 19 | $92,910 | $6,948 | 7.5% |
| 38570 | Removal of abdominal cavity lymph nodes using an endoscope | Facility | 2021 | 17 | 17 | $93,755 | $4,300 | 4.6% |
| 31622 | Diagnostic examination of lung airways using an endoscope | Facility | 2021 | 24 | 24 | $40,703 | $1,618 | 4.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 19 | $7,410 | $1,187 | 16.0% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 13 | 14 | $18,830 | $1,054 | 5.6% |
About David Jones
David Jones is a Vascular Surgery healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538238142.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Jones has received a total of $55,666 in payments from pharmaceutical and medical device companies, with $1,291 received in 2024. These payments were reported across 67 transactions from 18 companies. The most common payment nature is "Consulting Fee" ($31,781).
As a Medicare-enrolled provider, Jones has provided services to 1,759 Medicare beneficiaries, totaling 2,083 services with total Medicare billing of $453,665. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Vascular Surgery
- Other Specialties Thoracic Surgery (Cardiothoracic Vascular Surgery)
- Location New York, NY
- Active Since 11/07/2006
- Last Updated 08/21/2013
- Taxonomy Code 2086S0129X
- Entity Type Individual
- NPI Number 1538238142
Products in Payments
- TAGRISSO (Drug) $6,578
- NO PRODUCT DISCUSSED (Drug) $5,610
- LigaSure (Device) $4,219
- MS DISEASE STATE (Drug) $2,064
- TECENTRIQ (Biological) $1,363
- KEYTRUDA (Biological) $750.00
- Da Vinci Surgical System (Device) $460.91
- SIGNIA (Device) $384.92
- SPY Technology (Device) $166.44
- Endo GIA (Device) $103.96
- SPYGLASS (Device) $97.64
- LEMTRADA (Drug) $85.00
- METRA (Device) $77.89
- SuperDimension (Device) $74.25
- IMFINZI (Biological) $50.00
- BioMonitor (Device) $24.93
- Mitra Clip system (Device) $21.91
- VISERA ELITE (Device) $20.46
- MONARCH (Device) $19.89
- PORTICO (Device) $18.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Vascular Surgery Doctors in New York
John Lantis, Md, MD
Vascular Surgery — Payments: $1.0M
Dr. James Mckinsey, M.d, M.D
Vascular Surgery — Payments: $959,134
Brian De Rubertis, Md, MD
Vascular Surgery — Payments: $852,805
Peter Faries, M.d, M.D
Vascular Surgery — Payments: $524,140
Thomas Maldonado, M.d, M.D
Vascular Surgery — Payments: $267,839
Dr. Karan Garg, M.d, M.D
Vascular Surgery — Payments: $215,922